retatrutide trial safety clinical data This from Phase 3 trials for was announced yesterday at @amdiabetesassn # 🔬 Retatrutide — why cardiology

It exhibits bitterness and reduces blood glucose and urinary sugar levels when administered via IV injections of STZ at 40 mg/kg in Wistar rats, demonstrating anti-diabetic effects through GLP-1 receptor activity

But they can also cause side effects

GIP Receptor Activation The GIP receptor was the second piece of the puzzle, first introduced clinically with Tirzepatide

Risk of Obsessive-Compulsive Disorder in Pregnant and Postpartum Women

Collectively, polyamines contribute to synthesis, functioning, maintenance, and stability of nucleic acids, and support cellular processes related to transcription, translation, signaling, and post-translational modifications 90

Effects depend on the additive, your baseline nutritional status, and how deficient you were before starting